Stay updated on Repeat Intravitreal Injection Safety in Retinitis Pigmentosa Clinical Trial
Sign up to get notified when there's something new on the Repeat Intravitreal Injection Safety in Retinitis Pigmentosa Clinical Trial page.

Latest updates to the Repeat Intravitreal Injection Safety in Retinitis Pigmentosa Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, indicating a minor platform update rather than changes to study content.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check40 days agoChange DetectedThe page's revision indicator was updated from v3.6.0 to v3.6.3, signaling a backend or layout update to the study page without changes to the study details.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page now indicates that recruitment is closed for participants. In addition, new help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment heading formatting was updated with the revision label changing from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check61 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5. This indicates a small page update or patch was applied.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing the previous v3.5.3. This indicates a minor revision to the page or site framework without changes to the study data or core content.SummaryDifference0.1%

- Check104 days agoChange DetectedThe page’s displayed release/version number was updated from v3.5.0 to v3.5.3, reflecting a minor website/interface update rather than a change to the study record.SummaryDifference0.1%

Stay in the know with updates to Repeat Intravitreal Injection Safety in Retinitis Pigmentosa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Repeat Intravitreal Injection Safety in Retinitis Pigmentosa Clinical Trial page.